INCOME STATEMENT
Hester Biosciences Ltd.
BSE
Jun 03
1778.90
-28.50 ( -1.58%)
Volume
156
Prev. Close
1807.40
Open Price
1781.05
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 03
1786.80
-22.20 ( -1.23%)
Volume
2869
Prev. Close
1809.00
Open Price
1820.90
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
ISIN No
|
INE782E01017
|
Market Cap. ( ₹ in Cr. )
|
1520.01
|
P/BV
|
5.04
|
Book Value ( ₹ )
|
354.81
|
BSE Code
|
524669
|
52 Week High/Low ( ₹ )
|
3379/1243
|
FV/ML
|
10/1
|
P/E(X)
|
55.30
|
NSE Code
|
HESTERBIOEQ
|
Book Closure
|
29/08/2024
|
EPS ( ₹ )
|
32.31
|
Div Yield (%)
|
0.39
|
(₹ in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 286.47 | 283.46 | 249.09 | 215.50 | 190.90 |
Other Operating Revenues | 0.00 | 1.70 | 4.91 | 3.85 | 17.57 |
Total Operating Revenues | 286.47 | 285.16 | 254.00 | 219.35 | 208.48 |
| | | | | |
Other Income | 4.76 | 4.26 | 5.32 | 4.66 | 1.65 |
Total Revenue | 291.23 | 289.42 | 259.32 | 224.01 | 210.13 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 38.86 | 32.69 | 29.28 | 34.93 | 24.18 |
Purchase Of Stock-In Trade | 44.84 | 56.60 | 55.37 | 39.30 | 25.21 |
Changes In Inventories Of FG,WIP And Stock-In Trade | 9.97 | 10.36 | -4.77 | -12.53 | 4.01 |
Employee Benefit Expenses | 54.76 | 56.72 | 47.92 | 39.12 | 33.45 |
Finance Costs | 5.37 | 5.09 | 6.50 | 2.47 | 3.95 |
Depreciation And Amortisation Expenses | 8.58 | 9.78 | 9.79 | 9.50 | 9.63 |
Other Expenses | 87.10 | 81.45 | 71.32 | 57.96 | 49.64 |
Total Expenses | 249.47 | 252.69 | 215.40 | 170.75 | 150.06 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 41.76 | 36.73 | 43.92 | 53.26 | 60.06 |
| | | | | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -5.28 |
Profit/Loss Before Tax | 41.76 | 36.73 | 43.92 | 53.26 | 54.78 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 9.92 | 9.64 | 10.73 | 14.25 | 16.37 |
Deferred Tax | 0.00 | -0.06 | 0.86 | -0.51 | -1.48 |
Total Tax Expenses | 9.92 | 9.57 | 11.58 | 13.74 | 14.88 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 31.84 | 27.16 | 32.34 | 39.52 | 39.90 |
| | | | | |
Profit/Loss From Continuing Operations | 31.84 | 27.16 | 32.34 | 39.52 | 39.90 |
| | | | | |
Profit/Loss For The Period | 31.84 | 27.16 | 32.34 | 39.52 | 39.90 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 37.43 | 31.93 | 38.02 | 46.45 | 46.90 |
Diluted EPS (Rs.) | 37.43 | 31.93 | 38.02 | 46.45 | 46.90 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 0.00 | 6.81 | 8.51 | 8.51 | 5.62 |
Equity Dividend Rate (%) | 70.00 | 60.00 | 80.00 | 100.00 | 100.00 |